Skip to main content
All lobbying filings

VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC)

VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) filed a Q3 report for LOCUS BIOSCIENCES, INC. on October 19, 2026, reporting $80,000 in lobbying income.

Lobbying for LOCUS BIOSCIENCES, INC. · clinical-stage biotechnology company

All filings by VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) · Everything LOCUS BIOSCIENCES, INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
North Carolina

Official filing document

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues related to NIH and BARDA funding; implementation of FY26 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.5304/S.2587), H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75). Issues related to Department of Defense funding; FY27 Department of Defense Appropriations Act (H.R.9495).

 Bills named in this filing 4
  • H.R. 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
  • S. 2587
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
  • H.R. 7148
    Consolidated Appropriations Act, 2026
  • H.R. 9495
    Department of Defense Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem